Soyfood and isoflavone intake and risk of type 2 diabetes in Vietnamese adults

European Journal of Clinical Nutrition

Volumn 71, Issue 10, 2017, Pages 1186-1192

  Nguyen, C T ^a,b   Pham, N M ^a,c   Do, V V ^a   Binns, C W ^a   Hoang, V M ^d   Dang, D A ^b   Lee, A H ^a  

^a CURTIN UNIVERSITY   (Australia)

^b National Institute of Hygiene and Epidemiology   (Viet Nam)

^c Thai Nguyen University of Medicine and Pharmacy   (Viet Nam)

^d HANOI UNIVERSITY OF PUBLIC HEALTH   (Viet Nam)

Author keywords

[No Author keywords available]

Indexed keywords

DAIDZEIN; GENISTEIN; GLYCITEIN; ISOFLAVONE; ISOFLAVONE DERIVATIVE;

ADULT; AGE; AGED; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DIETARY INTAKE; DISEASE ASSOCIATION; FEEDING BEHAVIOR; FEMALE; GENDER; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MUNG BEAN; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT RISK; RISK ASSESSMENT; SOY FOOD; SOYBEAN MILK; TOFU; VALIDATION STUDY; VIET NAM; VIETNAMESE; BLOOD; HOSPITAL; MIDDLE AGED; QUESTIONNAIRE; RISK FACTOR; SOYBEAN;

ADULT; AGED; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; FEEDING BEHAVIOR; FEMALE; HOSPITALS; HUMANS; ISOFLAVONES; MALE; MIDDLE AGED; RISK FACTORS; SOYBEANS; SURVEYS AND QUESTIONNAIRES; VIETNAM;

EID: 85030653116     PISSN: 09543007     EISSN: 14765640     Source Type: Journal    
DOI: 10.1038/ejcn.2017.76     Document Type: Article

References (50)

1. International Diabetes Federation IDF Diabetes Atlas 2015.
2. N. C. D. Risk Factor Collaboration. Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants. Lancet 2016; 387: 1513-1530.
3. Esposito K, Chiodini P, Maiorino MI, Bellastella G, Panagiotakos D, Giugliano D. Which diet for prevention of type 2. diabetes? A meta-analysis of prospective studies. Endocrine 2014; 47: 107-116.
4. Murphy PA, Barua K, Hauck CC. Solvent extraction selection in the determination of isoflavones in soy foods. J Chromatogr B Analyt Technol Biomed Life Sci 2002; 777: 129-138.
5. Messina M, Nagata C, Wu AH. Estimated Asian adult soy protein and isoflavone intakes. Nutr Cancer 2006; 55: 1-12.
6. Talaei M, Pan A. Role of phytoestrogens in prevention and management of type 2. diabetes. World J Diabetes 2015; 6: 271-283.
7. Kwon DY, Daily JW 3rd, Kim HJ, Park S. Antidiabetic effects of fermented soybean products on type 2 diabetes. Nutr Res 2010; 30: 1-13.
8. Cho KW, Lee OH, Banz WJ, Moustaid-Moussa N, Shay NF, Kim YC. Daidzein and the daidzein metabolite, equol, enhance adipocyte differentiation and PPARgamma transcriptional activity. J Nutr Biochem 2010; 21: 841-847.
9. Villegas R, Gao Y-T, Yang G, Li H-L, Elasy TA, Zheng W et al. Legume and soy food intake and the incidence of type 2 diabetes in the Shanghai Women's Health Study. Am J Clin Nutr 2008; 87: 162-167.
10. Nanri A, Mizoue T, Takahashi Y, Kirii K, Inoue M, Noda M et al. Soy product and isoflavone intakes are associated with a lower risk of type 2 diabetes in overweight Japanese women. J Nutr 2010; 140: 580-586.
11. Mueller NT, Odegaard AO, Gross MD, Koh WP, Yu MC, Yuan JM et al. Soy intake and risk of type 2 diabetes in Chinese Singaporeans. Eur J Nutr 2012; 51: 1033-1040.
12. Tatsumi Y, Morimoto A, Deura K, Mizuno S, Ohno Y, Watanabe S. Effects of soybean product intake on fasting and postload hyperglycemia and type 2 diabetes in Japanese men with high body mass index: The Saku Study. J Diabetes Investig 2013; 4: 626-633.
13. Morimoto Y, Steinbrecher A, Kolonel LN, Maskarinec G. Soy consumption is not protective against diabetes in Hawaii: The Multiethnic Cohort. Eur J Clin Nutr 2011; 65: 279-282.
14. Ding M, Pan A, Manson JE, Willett WC, Malik V, Rosner B et al. Consumption of soy foods and isoflavones and risk of type 2 diabetes: a pooled analysis of three US cohorts. Eur J Clin Nutr 2016; 70: 1381-1387.
15. Zamora-Ros R, Forouhi NG, Sharp SJ, Gonzalez CA, Buijsse B, Guevara M et al. The association between dietary flavonoid and lignan intakes and incident type 2 diabetes in European populations: the EPIC-InterAct study. Diabetes Care 2013; 36: 3961-3970.
16. Ding M, Franke AA, Rosner BA, Giovannucci E, van Dam RM, Tworoger SS et al. Urinary isoflavonoids and risk of type 2 diabetes: a prospective investigation in US women. Br J Nutr 2015; 114: 1694-1701.
17. Ozen AE, Pons A, Tur JA. Worldwide consumption of functional foods: a systematic review. Nutr Rev 2012; 70: 472-481.
18. Inbaraj BS, Chen BH. Isoflavone ingestion by multiethnic populations: implications for health. In: Preedy VR (ed) Isoflavones: Chemistry, Analysis, Function and Effects. RSC Publishing: Cambridge, 2013, pp 349-364.
19. Nguyen CT, Pham NM, Lee AH, Binns CW. Prevalence of and risk factors for type 2 diabetes mellitus in Vietnam: a systematic review. Asia Pac J Public Health 2015; 27: 588-600.
20. Pham NM, Eggleston K. Diabetes prevalence and risk factors among Vietnamese adults: findings from community-based screening programs. Diabetes Care 2015; 38: e77-e78.
21. Huong NT, Ward M. Vietnam oilseeds and products soybean meal and vegetable oil update. GAIN Report Number: VM5019 (2015).
22. Nguyen CT, Pham NM, Tran DV, Lee AH, Binns CW. Lifestyle and diet in relation to risk of type 2 diabetes in Vietnam: a hospital-based case-control study. Springerplus 2016; 5: 687.
23. The World Health Organization. Definition and Diagnosis of Diabetes Mellitus and Intermediate Hyperglycemia. Report of a WHO/IDF consultation: Geneva, 2006.
24. Van Tran D, Van Hoang D, Nguyen CT, Lee AH. Validity and reliability of a food frequency questionnaire to assess habitual dietary intake in Northern Vietnam. Vietnam J Pub Health 2013; 1: 57-64.
25. Bhagwat S, Haytowitz DB, Holden JM. USDA Database for the isoflavone Content of Selected Foods Release 2.0. US Department of Agriculture: Maryland, 2008; 15.
26. Willett WC, Howe GR, Kushi LH. Adjustment for total energy intake in epidemiologic studies. Am J Clin Nutr 1997; 65: 1220S-1228S. discussion 1229S-1231S.
27. Zhang M, Lee AH, Binns CW. Physical activity and epithelial ovarian cancer risk: a case-control study in China. Int J Cancer 2003; 105: 838-843.
28. World Health Organization STEPwise approach to surveillance, 2002. Available at http://www.who.int/chp/steps/en/ (accessed 20. October 2016).
29. James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA 2014; 311: 507-520.
30. Hsieh CC, Maisonneuve P, Boyle P, Macfarlane GJ, Roberston C. Analysis of quantitative data by quantiles in epidemiologic studies: classification according to cases, noncases, or all subjects? Epidemiology 1991; 2: 137-140.
31. Durrleman S, Simon R. Flexible regression models with cubic splines. Stat Med 1989; 8: 551-561.
32. Ko KP, Kim CS, Ahn Y, Park SJ, Kim YJ, Park JK et al. Plasma isoflavone concentration is associated with decreased risk of type 2 diabetes in Korean women but not men: results from the Korean Genome and Epidemiology Study. Diabetologia 2015; 58: 726-735.
33. Yang G, Shu XO, Jin F, Elasy T, Li HL, Li Q et al. Soyfood consumption and risk of glycosuria: a cross-sectional study within the Shanghai Women's Health Study. Eur J Clin Nutr 2004; 58: 615-620.
34. Nakamoto M, Uemura H, Sakai T, Katsuura-Kamano S, Yamaguchi M, Hiyoshi M et al. Inverse association between soya food consumption and insulin resistance in Japanese adults. Public Health Nutr 2015; 18: 2031-2040.
35. Talaei M, Lee BL, Ong CN, van Dam RM, Yuan JM, Koh WP et al. Urine phytooestrogen metabolites are not significantly associated with risk of type 2 diabetes: the Singapore Chinese health study. Br J Nutr 2016; 115: 1607-1615.
36. Liu ZM, Chen YM, Ho SC. Effects of soy intake on glycemic control: a meta-analysis of randomized controlled trials. Am J Clin Nutr 2011; 93: 1092-1101.
37. Lee SA, Wen W, Xiang YB, Barnes S, Liu D, Cai Q et al. Assessment of dietary isoflavone intake among middle-aged Chinese men. J Nutr 2007; 137: 1011-1016.
38. Setchell KD. Phytoestrogens: the biochemistry, physiology, and implications for human health of soy isoflavones. Am J Clin Nutr 1998; 68: 1333S-1346S.
39. Rowland I, Faughnan M, Hoey L, Wahala K, Williamson G, Cassidy A. Bioavailability of phyto-oestrogens. Br J Nutr 2003; 89 (Suppl 1): S45-S58.
40. Chen L, Zhang YH, Huang T, Cai YD. Gene expression profiling gut microbiota in different races of humans. Sci Rep 2016; 6: 23075.
41. Li J, Jia H, Cai X, Zhong H, Feng Q, Sunagawa S et al. An integrated catalog of reference genes in the human gut microbiome. Nat Biotechnol 2014; 32: 834-841.
42. Setchell KD, Clerici C. Equol: history, chemistry, and formation. J Nutr 2010; 140: 1355S-1362S.
43. Ae Park S, Choi MS, Cho SY, Seo JS, Jung UJ, Kim MJ et al. Genistein and daidzein modulate hepatic glucose and lipid regulating enzyme activities in C57BL/KsJ-db/ db mice. Life Sci 2006; 79: 1207-1213.
44. Wang L, Waltenberger B, Pferschy-Wenzig EM, Blunder M, Liu X, Malainer C et al. Natural product agonists of peroxisome proliferator-activated receptor gamma (PPARgamma): a review. Biochem Pharmacol 2014; 92: 73-89.
45. Kostelac D, Rechkemmer G, Briviba K. Phytoestrogens modulate binding response of estrogen receptors alpha and beta to the estrogen response element. J Agric Food Chem 2003; 51: 7632-7635.
46. Muthyala RS, Ju YH, Sheng S, Williams LD, Doerge DR, Katzenellenbogen BS et al. Equol, a natural estrogenic metabolite from soy isoflavones: convenient preparation and resolution of R-and S-equols and their differing binding and biological activity through estrogen receptors alpha and beta. Bioorg Med Chem 2004; 12: 1559-1567.
47. Ding EL, Song Y, Malik VS, Liu S. Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA 2006; 295: 1288-1299.
48. Greenland S, Lash TL. Bias analysis. In: Rothman KJ, Greenland S, Lash TL (eds) Modern Epidemiology, 3rd edn. Lippincott-Raven: Philadelphia, 2008.
49. Orsini N, Bellocco R. A tool for deterministic and probabilistic sensitivity analysis of epidemiologic studies. Stat J 2008; 8: 29-48.
50. Ho-Pham LT, Do TT, Campbell LV, Nguyen TV. HbA1c-based classification reveals epidemic of diabetes and prediabetes in Vietnam. Diabetes Care 2016; 39: e93-e94.